Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

Biomerica, Inc. (NASDAQ:BMRAGet Free Report)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.36 and traded as low as $0.27. Biomerica shares last traded at $0.33, with a volume of 377,159 shares.

Biomerica Trading Up 16.9 %

The company has a market cap of $5.47 million, a price-to-earnings ratio of -0.88 and a beta of -1.10. The business has a 50-day moving average price of $0.33 and a 200 day moving average price of $0.36.

Biomerica (NASDAQ:BMRAGet Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%. The business had revenue of $1.81 million for the quarter.

Hedge Funds Weigh In On Biomerica

A hedge fund recently bought a new stake in Biomerica stock. Perritt Capital Management Inc acquired a new position in shares of Biomerica, Inc. (NASDAQ:BMRAFree Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned 0.42% of Biomerica at the end of the most recent quarter. Institutional investors and hedge funds own 22.28% of the company’s stock.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Recommended Stories

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.